Global trial shows targeted heart drug reduces obstructive hypertrophic cardiomyopathy in youth

A global clinical trial involving The Hospital for Sick Children (SickKids) has found that mavacamten—a heart medication previously approved for adults—can safely and effectively improve the flow of blood through compromised left ventricles…

Continue Reading

News Source: medicalxpress.com